SCHEMBL25388174

SCHEMBL25388174

NC(Cc1ccc(NC(=O)C(Cl)Cl)cc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.57
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ MAPT P10636 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ HPGD P15428 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ SLC7A5 Q01650 3/20 0.56
▸ PTGS1 P23219 3/20 0.54
▸ ALPI P09923 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ XIAP P98170 1/20 0.54
▸ HIF1A Q16665 5/20 0.52
▸ CYP3A4 P08684 3/20 0.52
▸ ALOX15 P16050 3/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ ABCB11 O95342 1/20 0.52
▸ CHRM2 P08172 1/20 0.52
▸ ADRA2A P08913 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25388169 1.00 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL20865323 0.84 KMT2A (0.57) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL25386567 0.84 SLC7A5 (0.56) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL25386565 0.84 SLC7A5 (0.56) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL1530915 0.83 SLC7A5 (0.54) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL12838404 0.83 SLC7A5 (0.54) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL1530907 0.83 SLC7A5 (0.54) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL25388820 0.82 NOS3 (0.64) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL25388823 0.82 NOS3 (0.64) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL4943107 0.82 SLC7A5 (0.61) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250197448-A1 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2025-06-19 — — US claimed
US-20250197448-A1 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2025-06-19 — — US disclosed
WO-2023173084-A9 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2023-12-14 — — WO disclosed
WO-2023173084-A1 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2023-09-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197448-A1 CYCLOPEPTIBODIES AND USES THEREOF FCGR3B, FCGRT, FCGR2A ALDH1A1 4523/4885SMN1; SMN2 4871/4885MEN1 4859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback